These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 18820278)
1. Prostate-specific antigen levels and subsequent prostate cancer: potential for screening. Helzsouer KJ; Newby J; Comstock GW Am J Epidemiol; 2008 Oct; 168(7):841-4. PubMed ID: 18820278 [TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen levels and subsequent prostate cancer: potential for screening. Helzlsouer KJ; Newby J; Comstock GW Cancer Epidemiol Biomarkers Prev; 1992; 1(7):537-40. PubMed ID: 1284590 [TBL] [Abstract][Full Text] [Related]
3. A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica. Coard KC; Skeete DH BJU Int; 2009 Jun; 103(11):1482-6. PubMed ID: 19076136 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen kinetics in localized and advanced prostate cancer. Fitzpatrick JM; Banu E; Oudard S BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674 [TBL] [Abstract][Full Text] [Related]
5. Prostate screening in patients with 46,XY disorders of sex development--is it necessary? Salmasi AH; Wisniewski AB; Novak TE; Gearhart JP; Migeon CJ; Lakshmanan Y J Urol; 2008 Oct; 180(4):1422-5; discussion 1425-6. PubMed ID: 18710761 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
7. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. Culp S; Porter M BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868 [TBL] [Abstract][Full Text] [Related]
8. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847 [TBL] [Abstract][Full Text] [Related]
9. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M Urol J; 2009; 6(3):182-8. PubMed ID: 19711272 [TBL] [Abstract][Full Text] [Related]
10. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer? Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011 [TBL] [Abstract][Full Text] [Related]
11. Tissue Resonance Interaction Method (TRIMprob) has the potential to be used alongside the recognized tests in the screening protocols for prostate cancer. Gokce O; Sanli O; Salmaslioglu A; Tunaci A; Ozsoy C; Ozcan F Int J Urol; 2009 Jun; 16(6):580-3. PubMed ID: 19456986 [TBL] [Abstract][Full Text] [Related]
12. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]. Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening: the continuing controversy. Wilbur J Am Fam Physician; 2008 Dec; 78(12):1377-84. PubMed ID: 19119557 [TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL; Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472 [TBL] [Abstract][Full Text] [Related]
15. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection. Schostak M; Schwall GP; Poznanović S; Groebe K; Müller M; Messinger D; Miller K; Krause H; Pelzer A; Horninger W; Klocker H; Hennenlotter J; Feyerabend S; Stenzl A; Schrattenholz A J Urol; 2009 Jan; 181(1):343-53. PubMed ID: 19012935 [TBL] [Abstract][Full Text] [Related]
16. The effect of acute urinary retention on serum prostate-specific antigen level. Aliasgari M; Soleimani M; Hosseini Moghaddam SM Urol J; 2005; 2(2):89-92. PubMed ID: 17629877 [TBL] [Abstract][Full Text] [Related]
17. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z; Liu J; Li S; Shen W Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463 [TBL] [Abstract][Full Text] [Related]
18. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Huo D; Hetzel JT; Roy H; Rubin DT Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678 [TBL] [Abstract][Full Text] [Related]
19. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
20. A framework for the identification of men at increased risk for prostate cancer. Roobol MJ; Schröder FH; Crawford ED; Freedland SJ; Sartor AO; Fleshner N; Andriole GL J Urol; 2009 Nov; 182(5):2112-20. PubMed ID: 19758625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]